中国小细胞肺癌放射治疗临床指南(2020版)

2021-12-28 e药安全 网络

中国小细胞肺癌放射治疗临床指南

来源:中华放射肿瘤学杂志

参考文献

中华医学会放射肿瘤治疗学分会,中国医师协会放射肿瘤治疗医师分会,中国抗癌协会放射治疗专业委员会,中国临床肿瘤学会肿瘤放疗专家委员会.中国小细胞肺癌放射治疗临床指南(2020版)[J].中华放射肿瘤学杂志,2020,29(8):608-614.DOI:10.3760/cma.j.cn113030-20200528-00285.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1744593, encodeId=3b501e4459323, content=<a href='/topic/show?id=b5dc228320b' target=_blank style='color:#2F92EE;'>#临床指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22832, encryptionId=b5dc228320b, topicName=临床指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943c35414419, createdName=kcb081, createdTime=Thu Oct 20 09:33:53 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181388, encodeId=83ae11813883a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:44:42 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085157, encodeId=e286108515ed9, content=可, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Tue Dec 28 17:56:33 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1744593, encodeId=3b501e4459323, content=<a href='/topic/show?id=b5dc228320b' target=_blank style='color:#2F92EE;'>#临床指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22832, encryptionId=b5dc228320b, topicName=临床指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943c35414419, createdName=kcb081, createdTime=Thu Oct 20 09:33:53 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181388, encodeId=83ae11813883a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:44:42 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085157, encodeId=e286108515ed9, content=可, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Tue Dec 28 17:56:33 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-01-06 ms5000000224637601

    学到了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1744593, encodeId=3b501e4459323, content=<a href='/topic/show?id=b5dc228320b' target=_blank style='color:#2F92EE;'>#临床指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22832, encryptionId=b5dc228320b, topicName=临床指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=943c35414419, createdName=kcb081, createdTime=Thu Oct 20 09:33:53 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181388, encodeId=83ae11813883a, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96e16408197, createdName=ms5000000224637601, createdTime=Thu Jan 06 15:44:42 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085157, encodeId=e286108515ed9, content=可, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Tue Dec 28 17:56:33 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 云舒

    0

相关资讯

今晚直播:60分钟解读肺癌免疫治疗新近进展

👉 30篇肺癌最新指南报名即得,前200位可申领肿瘤专业纸质书1本

Clin Cancer Res:PARPi Veliparib联合卡铂和依托泊苷治疗晚期小细胞肺癌的疗效和安全性

小细胞肺癌(SCLC)是一种神经内分泌癌,以侵袭性行为、细胞迅速分裂和早期转移为特征,约占肺癌的15%

J Clin Oncol:预防性脑放疗时避开海马区可在不降低预后的情况下保护认知功能

预防性脑放疗时避开海马区可在不降低预后的情况下保护认知功能

Nat Commun:Notch信号通路影响复发性小细胞肺癌患者对免疫检查点阻断治疗的疗效

小细胞肺癌(SCLC)是一种高度侵袭性的神经内分泌(NE)癌症,其约占所有肺癌类型的15%

中国科学院大学附属肿瘤医院李亚清:教授直播:C-TBNA和EBUS-TBNA在临床中的应用

👉 今晚19:00直播 | 扫码免费报名,0元获取30份最新指南合集